Effect of interferon β-1a on Death and Days Free From Mechanical Ventilation in Moderate to Severe ARDS

This randomized trial compares the effects of intravenous interferon β-1a vs placebo on 28-day mortality and on ventilator-free days in patients with moderate to severe acute respiratory distress syndrome (ARDS).
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research